SO
DMAC icon

STRS Ohio’s DiaMedica Therapeutics DMAC Stock Holding History

STRS Ohio’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.2K Hold
2,300
– – ﹤0.01% 2124
2026
Q1 		$15.6K Hold
2,300
– – ﹤0.01% 2069
2025
Q4 		$18.3K Sell
2,300
-6,800
-75% -$50.8K ﹤0.01% 2111
2025
Q3 		$62.5K Buy
9,100
+1,500
+20% +$8.14K ﹤0.01% 1959
2025
Q2 		$29.6K Buy
+7,600
New +$29.6K ﹤0.01% 2097

Other funds holding DMAC

CLG
Cooperman Leon G $3.55B AUM 41.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

STRS Ohio's DMAC Position: Q2 2026 in Review

STRS Ohio held its DiaMedica Therapeutics (DMAC) position steady in Q2 2026 at 2,300 shares worth $16.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2124.

STRS Ohio first reported a position in DMAC in Q2 2025 and has held it in 5 quarters since. The position peaked at $62.5K in Q3 2025. 89 funds tracked by Wall St. Rank hold DMAC as of Q2 2026.

  • STRS Ohio held 2,300 shares of DiaMedica Therapeutics worth $16.2K as of Q2 2026.
  • STRS Ohio left its DiaMedica Therapeutics share count unchanged in Q2 2026.
  • DiaMedica Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #2124 holding.
  • STRS Ohio first reported a position in DiaMedica Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • STRS Ohio's DiaMedica Therapeutics position peaked at $62.5K in Q3 2025.
  • 89 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.